FC
BIIB icon

Financial Consulate’s Biogen BIIB Stock Holding History

Financial Consulate’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02K Buy
11
+7
+175% +$1.29K ﹤0.01% 979
2025
Q4 		$704 Hold
4
– – ﹤0.01% 1087
2025
Q3 		$561 Buy
+4
New +$541 ﹤0.01% 965

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Financial Consulate's BIIB Position: Q1 2026 in Review

Financial Consulate increased its Biogen (BIIB) stake by 175% in Q1 2026, buying an estimated $1.29K and bringing the position to 11 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #979.

Financial Consulate first reported a position in BIIB in Q3 2025 and has held it in 3 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Financial Consulate held 11 shares of Biogen worth $2.02K as of Q1 2026.
  • Financial Consulate bought 7 Biogen shares in Q1 2026, an estimated $1.29K.
  • Biogen made up ﹤0.01% of Financial Consulate's portfolio in Q1 2026, its #979 holding.
  • Financial Consulate first reported a position in Biogen in Q3 2025 and has held it in 3 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.